Malignant News and Research

RSS

Longer-lived, but less toxic drug may work better for pancreatic cancer

Unlike many other cancers, most pancreatic tumors are rock hard.

9 Aug 2019

Study shows how cigarette smoke drives tumor aggressiveness in head and neck cancer

Head and neck cancer is the sixth most common cancer in the world. The vast majority of cases are head and neck squamous cell carcinoma, a type of cancer that arises in the outer layer of the skin and mucous membranes of the mouth, nose and throat.

8 Aug 2019

New nanovaccine for deadly skin cancer

Tel Aviv scientists have published their version of a vaccine against the deadly skin cancer malignant melanoma, which arises from the pigment producing cells of the skin. This is the most feared form of skin cancer, with a high tendency to metastasize to distant parts of the body, including the brain.

6 Aug 2019

New blood test can detect clinically significant prostate cancer in high-risk patients

An international research team at Mahidol University in Bangkok, Thailand, has developed a new blood test capable of detecting clinically significant prostate cancer in high-risk patients, as reported in the medical journal Cancers on 27 July 2019.

6 Aug 2019

Research offers molecular details of pancreatic cancer's ability to invade and evade

Two known gene mutations induce pathways that enhance pancreatic cancer's ability to invade tissues and evade the immune system.

6 Aug 2019

Biomarkers reveal increase in thyroid cancer incidence among WTC responders

The incidence of thyroid cancer among first responders who volunteered or were employed as firefighters, rescue personnel and cleanup workers at Ground Zero in New York on or after September 11, 2001, is three times higher than that in the general population.

5 Aug 2019

Novel medical device protects healthy organs from radiation exposure during particle therapy

Kobe University and Alfresa Pharma Corporation develop a novel medical device with non-woven fabric style made of bioabsorbable material.

5 Aug 2019

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

3 Aug 2019

Canine tumor appears immortal, spreads from dog to dog across all boundaries

A new study has revealed that the oldest and most widespread cancer cell line in the world is the contagious dog cancer called CTVT. This is among the few transmissible cancers. The canine transmissible venereal tumor (CTVT) has been found to cause sexually transmitted tumors in dogs for over 8,500 years.

2 Aug 2019

Antimicrobial peptides that help protect against infection defend against cancer

An antimicrobial agent called Defensin kills tumor cells and shrinks tumor size in fruit flies, with help from a pathway that flags the cells for destruction.

31 Jul 2019

Study confirms link between treatment results and frequency of service provided

Does the treatment success of a certain procedure depend on the number of cases in a hospital or on how often the doctors working there have already performed this procedure?

30 Jul 2019

New breast cancer drug identified as a potential therapy for glioblastoma

The Ivy Brain Tumor Center at the Barrow Neurological Institute, has released the results of its recent Phase 0 clinical trial of the breast cancer drug ribociclib (Kisqali) for the treatment of recurrent glioblastoma.

25 Jul 2019

Researchers aim to develop a plaster for detecting skin cancer

Skin cancer is one of the most common types of cancer and, in Sweden, malignant melanoma is the most increasing of all cancer types.

25 Jul 2019

Researchers turn to single-cell analysis to understand a pediatric brain tumor

Investigators at St. Jude Children's Research Hospital and Massachusetts General Hospital, alongside others, have revealed the cells of origin for specific subtypes of medulloblastoma, the most common malignant pediatric brain tumor.

25 Jul 2019

Fat cells may be egging on melanoma cells to become more aggressive

A new study has shown that fat cells could be implicated in the transformation of the melanoma cells in the skin into highly malignant cells that spread to the different organs of the body. A team from the Tel Aviv University, led by Prof. Carmit Levy and Dr. Tamar Golan of the Department of Human Genetics and Biochemistry at TAU's Sackler School of Medicine published their findings in the journal Science Signaling this week.

24 Jul 2019

Women who inherit BRCA mutations have high risk of developing cancer

Women who inherit harmful mutations in the BRCA1 or BRCA2 gene are at high risk of developing breast and ovarian cancer.

24 Jul 2019

Four young scientists receives Damon Runyon-Sohn Pediatric Cancer Fellowship Award

The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Fellowship Award, committing nearly $1 million to help address a critical shortage of funding for pediatric cancer research.

17 Jul 2019

Repurposing a heart drug could increase survival rate of children with ependymoma

Researchers at the University of Nottingham have discovered that repurposing a heart drug could significantly increase the survival rate for children with ependymoma - a type of brain tumor.

16 Jul 2019

UMass Amherst scientist receives $792,000 grant to advance cancer immunotherapy research

Biomedical engineer Ashish Kulkarni, assistant professor of chemical engineering at the University of Massachusetts Amherst, has been awarded a four-year, $792,000 grant from the American Cancer Society to advance his interdisciplinary lab's promising cancer immunotherapy research.

16 Jul 2019

Using machine learning algorithm to accurately diagnose breast cancer

Breast cancer is the leading cause of cancer-related death among women. It is also difficult to diagnose. Nearly one in 10 cancers is misdiagnosed as not cancerous, meaning that a patient can lose critical treatment time.

14 Jul 2019

Malignant News and Research

Longer-lived, but less toxic drug may work better for pancreatic cancer

Study shows how cigarette smoke drives tumor aggressiveness in head and neck cancer

New nanovaccine for deadly skin cancer

New blood test can detect clinically significant prostate cancer in high-risk patients

Research offers molecular details of pancreatic cancer's ability to invade and evade

Biomarkers reveal increase in thyroid cancer incidence among WTC responders

Novel medical device protects healthy organs from radiation exposure during particle therapy

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Canine tumor appears immortal, spreads from dog to dog across all boundaries

Antimicrobial peptides that help protect against infection defend against cancer

Study confirms link between treatment results and frequency of service provided

New breast cancer drug identified as a potential therapy for glioblastoma

Researchers aim to develop a plaster for detecting skin cancer

Researchers turn to single-cell analysis to understand a pediatric brain tumor

Fat cells may be egging on melanoma cells to become more aggressive

Women who inherit BRCA mutations have high risk of developing cancer

Four young scientists receives Damon Runyon-Sohn Pediatric Cancer Fellowship Award

Repurposing a heart drug could increase survival rate of children with ependymoma

UMass Amherst scientist receives $792,000 grant to advance cancer immunotherapy research

Using machine learning algorithm to accurately diagnose breast cancer

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News